2025年虛擬活體組織切片全球市場報告

預計未來幾年虛擬活體組織切片市場規模將快速成長。到2029年，該市場規模將成長至11.2億美元，年複合成長率（CAGR）為12.0%。預測期內的預期成長受諸多因素驅動，例如對經濟高效的醫療保健解決方案的日益關注、對預防醫學的重視、對個性化醫療日益成長的需求、對微創癌症治療日益成長的興趣以及精準腫瘤學日益成長的重要性。預測期內的主要趨勢包括先進成像感測器的發展、多模態切片檢查技術的演進、與機器人技術的整合以提高準確性、非侵入性生物標記檢測的創新以及3D(3D) 可視化工具的採用。

預計腫瘤疾病盛行率的不斷上升將在未來幾年顯著推動虛擬活體組織切片市場的成長。腫瘤疾病是指與癌症相關的健康狀況，其特徵是體內細胞異常增生和擴散。癌症患者數量的增加主要歸因於不良飲食、缺乏運動、吸煙以及進一步接觸環境污染物等生活方式因素。虛擬活體組織切片透過提供非侵入性即時影像解決方案來支援這些疾病的診斷和監測，該解決方案最大限度地減少了對傳統組織切片檢查的需求，同時提高了診斷的準確性和病患安全性。例如，2024 年 7 月，澳洲健康與福利研究所報告稱，澳洲的癌症診斷數量從 2021 年的 156,781 例增加到 2022 年的 160,570 例，增加了 3,789 例。因此，腫瘤疾病盛行率的不斷上升正在刺激虛擬活體組織切片市場的擴張。

虛擬活體組織切片市場的關鍵參與者正在優先開發和獲得磁振造影波譜 (MRS) 平台等先進技術的監管批准，以提高非侵入性診斷的準確性並支援早期疾病核准和個人化醫療。 MRS 是一種非侵入性影像方法，它透過提供組織的詳細分子資訊來幫助虛擬活體組織切片，從而實現即時疾病監測並無需手術。例如，2023 年 11 月，美國健康科技公司 BrainSpec Inc. 獲得了美國食品藥物管理局(FDA) 對其 AI 驅動的 BrainSpec 平台的核准。該平台使用人工智慧分析 MR 波譜數據以檢測 2-羥基戊二酸等腦代謝物，從而實現非侵入性虛擬切片檢查，以診斷神經膠質瘤、阿茲海默症和多發性硬化症。該系統與標準 MRI 掃描儀整合，可自動進行數據分析，在幾分鐘內提供結果，並依靠腦化學參考資料資料庫來提高診斷信心。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球虛擬活體組織切片PESTEL分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球虛擬活體組織切片市場：成長率分析
• 全球虛擬活體組織切片市場表現：規模與成長，2019-2024
• 全球虛擬活體組織切片市場預測：規模與成長，2024-2029 年，2034 年
• 全球虛擬活體組織切片總目標市場（TAM）

第6章市場區隔

• 全球虛擬活體組織切片市場依治療領域、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 腫瘤疾病
• 神經系統疾病
• 心血管疾病
• 眼科疾病
• 內分泌失調
• 胃腸道疾病
• 其他目標治療領域
• 全球癌症虛擬活體組織切片市場現況及預測（2019-2024 年、2024-2029 年及 2034 年）
• 固態惡性腫瘤
• 乳癌
• 肺癌
• 攝護腺癌
• 大腸直腸癌
• 腦腫瘤
• 其他癌症標靶
• 全球虛擬活體組織切片市場影像技術現況及預測，2019-2024 年、2024-2029 年、2034 年
• 磁振造影
• 電腦斷層掃描
• X光
• 超音波
• 其他成像技術
• 全球虛擬活體組織切片市場：按最終用戶、業績和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院和診所
• 研究機構和診斷中心
• 其他最終用戶
• 全球虛擬活體組織切片市場按腫瘤疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 肺癌
• 乳癌
• 攝護腺癌
• 大腸直腸癌
• 肝癌
• 腦腫瘤
• 其他癌症
• 全球虛擬活體組織切片市場細分（按神經系統疾病類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
• 阿茲海默症
• 帕金森氏症
• 多發性硬化症
• 癲癇
• 腦損傷
• 中風
• 其他神經系統疾病
• 全球虛擬活體組織切片市場，依心血管疾病類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 冠狀動脈疾病
• 心臟衰竭
• 心律不整
• 主動脈瘤
• 心臟瓣膜疾病
• 心肌梗塞
• 其他心血管疾病
• 全球虛擬活體組織切片市場細分（按眼科疾病類型、表現和預測），2019-2024 年、2024-2029 年、2034 年
• 老齡化黃斑部病變
• 糖尿病視網膜病變
• 青光眼
• 視網膜靜脈阻塞
• 白內障
• 其他眼科疾病
• 全球虛擬活體組織切片市場按內分泌疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 糖尿病
• 甲狀腺疾病
• 腎上腺疾病
• 腦下垂體疾病
• 副甲狀腺疾病
• 其他內分泌疾病
• 全球虛擬活體組織切片市場按胃腸道疾病類型、表現和預測細分，2019-2024 年、2024-2029 年、2034 年
• 發炎性腸道疾病
• 結腸息肉
• 胃潰瘍
• 肝硬化
• 胰臟疾病
• 肝炎
• 其他胃腸道疾病
• 全球虛擬活體組織切片市場其他目標治療領域細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
• 肌肉骨骼疾病
• 腎臟疾病
• 肺部疾病
• 血液系統疾病
• 皮膚病
• 感染疾病
• 其他條款

第7章 區域和國家分析

• 全球虛擬活體組織切片市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球虛擬活體組織切片市場：按國家/地區、業績和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 虛擬活體組織切片市場：競爭格局
• 虛擬活體組織切片市場：公司簡介
  • Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Hologic Inc.
• Illumina Inc.
• Guardant Health Inc.
• Esaote SpA
• Samsung Medison Co Ltd.
• Telix Pharmaceuticals Limited
• Freenome Holdings Inc.
• Perspectum Ltd.
• QUIBIM SL
• IQ-AI Limited
• BrainSpec Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年虛擬活體組織切片市場：提供新機會的國家
• 2029年虛擬活體組織切片市場：細分市場帶來新機會
• 2029年虛擬活體組織切片市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Virtual biopsy is a non-invasive diagnostic method that leverages advanced imaging technologies and computer algorithms to analyze tissues for signs of disease. Its primary goal is to identify abnormalities, such as tumors or infections, without the need for traditional tissue sampling, minimizing risks and recovery time for patients. This technique is safer, faster, and less painful compared to conventional biopsies.

The main therapeutic areas targeted by virtual biopsy include oncology, neurology, cardiology, ophthalmology, endocrinology, gastroenterology, and other related conditions. Oncological disorders involve diseases characterized by the uncontrolled growth and spread of abnormal cells, commonly known as cancer, which can affect various organs and tissues. Virtual biopsy is used for detecting a wide range of cancers, including solid tumors, breast cancer, lung cancer, prostate cancer, colorectal cancer, brain cancer, and others. The imaging technologies utilized in virtual biopsy include magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, among others, and are employed by end users such as hospitals, clinics, research institutes, diagnostic centers, and more.

The virtual biopsy market research report is one of a series of new reports from The Business Research Company that provides virtual biopsy market statistics, including the virtual biopsy industry's global market size, regional shares, competitors with the virtual biopsy market share, detailed virtual biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the virtual biopsy market. This virtual biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The virtual biopsy market size has grown rapidly in recent years. It will grow from $0.63 billion in 2024 to $0.71 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth observed during the historic period can be attributed to the increasing demand for non-invasive diagnostic techniques, a growing preference for early disease detection, enhanced efficiency in medical imaging software, greater patient convenience and comfort, and the expanding availability of telemedicine services.

The virtual biopsy market size is expected to see rapid growth in the next few years. It will grow to $1.12 billion in 2029 at a compound annual growth rate (CAGR) of 12.0%. The expected growth in the forecast period is driven by factors such as a greater focus on cost-effective healthcare solutions, an emphasis on preventive healthcare, increasing demand for personalized medicine, rising interest in minimally invasive cancer treatments, and the growing significance of precision oncology. Key trends in the forecast period include the development of advanced imaging sensors, the evolution of multimodal biopsy techniques, integration with robotics for enhanced precision, innovations in non-invasive biomarker detection, and the incorporation of three-dimensional (3D) visualization tools.

The increasing prevalence of oncological disorders is anticipated to significantly drive the growth of the virtual biopsy market in the coming years. Oncological disorders refer to cancer-related health conditions characterized by the abnormal growth and spread of cells within the body. This rise in cancer cases is largely attributed to lifestyle factors such as poor dietary habits, physical inactivity, tobacco consumption, and greater exposure to environmental pollutants. Virtual biopsy supports the diagnosis and monitoring of these disorders by offering non-invasive, real-time imaging solutions that minimize the need for traditional tissue biopsies while enhancing diagnostic precision and patient safety. For example, in July 2024, the Australian Institute of Health and Welfare reported that cancer diagnoses in Australia increased to 160,570 in 2022, up from 156,781 in 2021-an increase of 3,789 cases. As a result, the growing incidence of oncological disorders is fueling the expansion of the virtual biopsy market.

Key players in the virtual biopsy market are prioritizing the development of advanced technologies and regulatory approvals, such as magnetic resonance spectroscopy (MRS) platforms, to improve the accuracy of non-invasive diagnostics and support early disease detection and personalized care. MRS is a non-invasive imaging method that assists virtual biopsy by delivering detailed molecular information of tissues, enabling real-time disease monitoring and eliminating the need for surgical procedures. For instance, in November 2023, BrainSpec Inc., a U.S.-based healthtech company, received approval from the U.S. Food and Drug Administration (FDA) for its AI-powered BrainSpec platform. This platform analyzes MR spectroscopy data using artificial intelligence to detect brain metabolites such as 2-hydroxyglutarate, enabling non-invasive virtual biopsies for diagnosing gliomas, Alzheimer's disease, and multiple sclerosis. The system integrates with standard MRI scanners, automates data analysis, delivers results within minutes, and relies on a reference database of brain chemistry to improve diagnostic reliability.

In July 2022, Quibim S.L., a healthtech firm based in Spain, entered a partnership with Microsoft Corporation to develop artificial intelligence-powered virtual biopsy tools. This collaboration seeks to advance non-invasive diagnostic capabilities by merging Quibim's AI-based imaging solutions with Microsoft's Azure cloud infrastructure. The goal is to enhance disease detection accuracy and minimize dependence on conventional biopsy techniques. Microsoft Corporation, headquartered in the U.S., is a globally recognized technology company known for its software products and digital services.

Major players in the virtual biopsy market are Canon Inc., Siemens Healthineers AG, GE Healthcare, Quest Diagnostics Incorporated, Olympus Corporation, Hologic Inc., Illumina Inc., Guardant Health Inc., Esaote S.p.A, Samsung Medison Co. Ltd., Telix Pharmaceuticals Limited, Freenome Holdings Inc., Perspectum Ltd., QUIBIM S.L, IQ-AI Limited, BrainSpec Inc., Oncoustics Inc., ImageBiopsy Lab GmbH, AI Metrics LLC, and Deep Bio Inc.

North America was the largest region in the virtual biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in virtual biopsy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the virtual biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The virtual biopsy market consists of revenues earned by entities by providing services such as imaging diagnostics, artificial intelligence (AI)-based interpretation, biomarker testing, telemedicine services, and three-dimensional (3D) tissue modeling. The market value includes the value of related goods sold by the service provider or included within the service offering. The virtual biopsy market also includes sales of biopsy needle systems, artificial intelligence (AI)-based diagnostic tools, endoscopic systems, and photoacoustic imaging devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Virtual Biopsy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on virtual biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for virtual biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The virtual biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Target Thrapeutic Areas: Oncological Disorders; Neurological Disorders; Cardiovascular Disorders; Ophthalmological Disorders; Endocrine Disorders; Gastrointestinal Disorders; Other Target Therapeutic Areas
• 2) By Cancer Targeted: Solid Malignancies; Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Cancer; Other Cancer Targeteds
• 3) By Imaging Technologies: Magnetic Resonance Imaging; Computed Tomography; X-Ray; Ultrasound; Other Imaging Technologies
• 4) By End Users: Hospitals And Clinics; Research Institutes And Diagnostic Centers; Other End Users
• Subsegments:
• 1) By Oncological Disorders: Lung Cancer; Breast Cancer; Prostate Cancer; Colorectal Cancer; Liver Cancer; Brain Tumors; Other Cancers
• 2) By Neurological Disorders: Alzheimer's Disease; Parkinson's Disease; Multiple Sclerosis; Epilepsy; Brain Injuries; Stroke; Other Neurological Conditions
• 3) By Cardiovascular Disorders: Coronary Artery Disease; Heart Failure; Arrhythmias; Aortic Aneurysm; Valvular Heart Disease; Myocardial Infarction; Other Cardiovascular Conditions
• 4) By Ophthalmological Disorders: Age-Related Macular Degeneration; Diabetic Retinopathy; Glaucoma; Retinal Vein Occlusion; Cataracts; Other Eye Disorders
• 5) By Endocrine Disorders: Diabetes Mellitus; Thyroid Disorders; Adrenal Gland Disorders; Pituitary Gland Disorders; Parathyroid Disorders; Other Endocrine Conditions
• 6) By Gastrointestinal Disorders: Inflammatory Bowel Disease; Colorectal Polyps; Gastric Ulcers; Liver Cirrhosis; Pancreatic Disorders; Hepatitis; Other Gastrointestinal Conditions
• 7) By Other Target Therapeutic Areas: Musculoskeletal Disorders; Renal Disorders; Pulmonary Disorders; Hematologic Disorders; Dermatological Disorders; Infectious Diseases; Other Miscellaneous Conditions
• Companies Mentioned: Canon Inc.; Siemens Healthineers AG; GE Healthcare; Quest Diagnostics Incorporated; Olympus Corporation
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Virtual Biopsy Market Characteristics

3. Virtual Biopsy Market Trends And Strategies

4. Virtual Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Virtual Biopsy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Virtual Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Virtual Biopsy Market Growth Rate Analysis
• 5.4. Global Virtual Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Virtual Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Virtual Biopsy Total Addressable Market (TAM)

6. Virtual Biopsy Market Segmentation

• 6.1. Global Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncological Disorders
• Neurological Disorders
• Cardiovascular Disorders
• Ophthalmological Disorders
• Endocrine Disorders
• Gastrointestinal Disorders
• Other Target Therapeutic Areas
• 6.2. Global Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Malignancies
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Colorectal Cancer
• Brain Cancer
• Other Cancer Targeteds
• 6.3. Global Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging
• Computed Tomography
• X-Ray
• Ultrasound
• Other Imaging Technologies
• 6.4. Global Virtual Biopsy Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Research Institutes And Diagnostic Centers
• Other End Users
• 6.5. Global Virtual Biopsy Market, Sub-Segmentation Of Oncological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lung Cancer
• Breast Cancer
• Prostate Cancer
• Colorectal Cancer
• Liver Cancer
• Brain Tumors
• Other Cancers
• 6.6. Global Virtual Biopsy Market, Sub-Segmentation Of Neurological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Alzheimer's Disease
• Parkinson's Disease
• Multiple Sclerosis
• Epilepsy
• Brain Injuries
• Stroke
• Other Neurological Conditions
• 6.7. Global Virtual Biopsy Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Coronary Artery Disease
• Heart Failure
• Arrhythmias
• Aortic Aneurysm
• Valvular Heart Disease
• Myocardial Infarction
• Other Cardiovascular Conditions
• 6.8. Global Virtual Biopsy Market, Sub-Segmentation Of Ophthalmological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Age-Related Macular Degeneration
• Diabetic Retinopathy
• Glaucoma
• Retinal Vein Occlusion
• Cataracts
• Other Eye Disorders
• 6.9. Global Virtual Biopsy Market, Sub-Segmentation Of Endocrine Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diabetes Mellitus
• Thyroid Disorders
• Adrenal Gland Disorders
• Pituitary Gland Disorders
• Parathyroid Disorders
• Other Endocrine Conditions
• 6.10. Global Virtual Biopsy Market, Sub-Segmentation Of Gastrointestinal Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Disease
• Colorectal Polyps
• Gastric Ulcers
• Liver Cirrhosis
• Pancreatic Disorders
• Hepatitis
• Other Gastrointestinal Conditions
• 6.11. Global Virtual Biopsy Market, Sub-Segmentation Of Other Target Therapeutic Areas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Musculoskeletal Disorders
• Renal Disorders
• Pulmonary Disorders
• Hematologic Disorders
• Dermatological Disorders
• Infectious Diseases
• Other Miscellaneous Conditions

7. Virtual Biopsy Market Regional And Country Analysis

• 7.1. Global Virtual Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Virtual Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Virtual Biopsy Market

• 8.1. Asia-Pacific Virtual Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Virtual Biopsy Market

• 9.1. China Virtual Biopsy Market Overview
• 9.2. China Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Virtual Biopsy Market

• 10.1. India Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Virtual Biopsy Market

• 11.1. Japan Virtual Biopsy Market Overview
• 11.2. Japan Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Virtual Biopsy Market

• 12.1. Australia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Virtual Biopsy Market

• 13.1. Indonesia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Virtual Biopsy Market

• 14.1. South Korea Virtual Biopsy Market Overview
• 14.2. South Korea Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Virtual Biopsy Market

• 15.1. Western Europe Virtual Biopsy Market Overview
• 15.2. Western Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Virtual Biopsy Market

• 16.1. UK Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Virtual Biopsy Market

• 17.1. Germany Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Virtual Biopsy Market

• 18.1. France Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Virtual Biopsy Market

• 19.1. Italy Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Virtual Biopsy Market

• 20.1. Spain Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Virtual Biopsy Market

• 21.1. Eastern Europe Virtual Biopsy Market Overview
• 21.2. Eastern Europe Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Virtual Biopsy Market

• 22.1. Russia Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Virtual Biopsy Market

• 23.1. North America Virtual Biopsy Market Overview
• 23.2. North America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Virtual Biopsy Market

• 24.1. USA Virtual Biopsy Market Overview
• 24.2. USA Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Virtual Biopsy Market

• 25.1. Canada Virtual Biopsy Market Overview
• 25.2. Canada Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Virtual Biopsy Market

• 26.1. South America Virtual Biopsy Market Overview
• 26.2. South America Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Virtual Biopsy Market

• 27.1. Brazil Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Virtual Biopsy Market

• 28.1. Middle East Virtual Biopsy Market Overview
• 28.2. Middle East Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Virtual Biopsy Market

• 29.1. Africa Virtual Biopsy Market Overview
• 29.2. Africa Virtual Biopsy Market, Segmentation By Target Therapeutic Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Virtual Biopsy Market, Segmentation By Cancer Targeted, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Virtual Biopsy Market, Segmentation By Imaging Technologies, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Virtual Biopsy Market Competitive Landscape And Company Profiles

• 30.1. Virtual Biopsy Market Competitive Landscape
• 30.2. Virtual Biopsy Market Company Profiles
  • 30.2.1. Canon Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GE Healthcare Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Olympus Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Virtual Biopsy Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. Illumina Inc.
• 31.3. Guardant Health Inc.
• 31.4. Esaote S.p.A
• 31.5. Samsung Medison Co Ltd.
• 31.6. Telix Pharmaceuticals Limited
• 31.7. Freenome Holdings Inc.
• 31.8. Perspectum Ltd.
• 31.9. QUIBIM S.L
• 31.10. IQ-AI Limited
• 31.11. BrainSpec Inc.

32. Global Virtual Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Virtual Biopsy Market

34. Recent Developments In The Virtual Biopsy Market

35. Virtual Biopsy Market High Potential Countries, Segments and Strategies

• 35.1 Virtual Biopsy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Virtual Biopsy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Virtual Biopsy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer